Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21268717rdf:typepubmed:Citationlld:pubmed
pubmed-article:21268717lifeskim:mentionsumls-concept:C0023980lld:lifeskim
pubmed-article:21268717lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:21268717lifeskim:mentionsumls-concept:C0013878lld:lifeskim
pubmed-article:21268717lifeskim:mentionsumls-concept:C0085732lld:lifeskim
pubmed-article:21268717lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:21268717lifeskim:mentionsumls-concept:C0596263lld:lifeskim
pubmed-article:21268717pubmed:issue2lld:pubmed
pubmed-article:21268717pubmed:dateCreated2011-1-27lld:pubmed
pubmed-article:21268717pubmed:abstractTextAs therapeutic uses of high-LET radiation become more prevalent and human space exploration continues to be a focus of NASA, it is important to understand the biological effects of high-LET radiation and the role of genetics in sensitivity to high-LET radiation. To study genetic susceptibility to radiation, we used mice deficient in Atm activity (Atm?SRI). ATM is important in DNA repair, apoptosis and cell cycle regulation. Although homozygous mutations in ATM are rare, the prevalence of ATM heterozygosity is estimated to be 1% and results in an increased cancer risk. We found that the effects of 1 Gy 1 GeV/nucleon ??Fe particles on life span and tumorigenesis are genotype- and sex-specific. Significant effects of 1 Gy 1 GeV/nucleon ??Fe particles on incidence of non-cancer end points were seen; however, 2 Gy 1 GeV/nucleon ??Fe particles significantly affected neuromotor ability. Our results represent an extensive investigation into the late effects of high-LET radiation exposure in a sex- and genotype-dependent manner and provide a baseline for understanding the long-term risks of high-LET radiation.lld:pubmed
pubmed-article:21268717pubmed:languageenglld:pubmed
pubmed-article:21268717pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21268717pubmed:citationSubsetIMlld:pubmed
pubmed-article:21268717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21268717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21268717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21268717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21268717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21268717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21268717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21268717pubmed:statusMEDLINElld:pubmed
pubmed-article:21268717pubmed:monthFeblld:pubmed
pubmed-article:21268717pubmed:issn1938-5404lld:pubmed
pubmed-article:21268717pubmed:authorpubmed-author:SchiestlRober...lld:pubmed
pubmed-article:21268717pubmed:authorpubmed-author:RelieneRamune...lld:pubmed
pubmed-article:21268717pubmed:authorpubmed-author:KellyOwenOlld:pubmed
pubmed-article:21268717pubmed:authorpubmed-author:YamamotoMitsu...lld:pubmed
pubmed-article:21268717pubmed:authorpubmed-author:FlemingSheila...lld:pubmed
pubmed-article:21268717pubmed:authorpubmed-author:HaferKurtKlld:pubmed
pubmed-article:21268717pubmed:authorpubmed-author:HackeKatrinKlld:pubmed
pubmed-article:21268717pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21268717pubmed:volume175lld:pubmed
pubmed-article:21268717pubmed:ownerNLMlld:pubmed
pubmed-article:21268717pubmed:authorsCompleteYlld:pubmed
pubmed-article:21268717pubmed:pagination231-9lld:pubmed
pubmed-article:21268717pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:meshHeadingpubmed-meshheading:21268717...lld:pubmed
pubmed-article:21268717pubmed:year2011lld:pubmed
pubmed-article:21268717pubmed:articleTitleEffects of 1 GeV/nucleon ??Fe particles on longevity, carcinogenesis and neuromotor ability in Atm-deficient mice.lld:pubmed
pubmed-article:21268717pubmed:affiliationDepartment of Pathology and Laboratory Medicine, University of California-Los Angeles, 650 Charles E. Young Dr. South, Los Angeles, CA 90095, USA.lld:pubmed
pubmed-article:21268717pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21268717pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed